CLINICAL_TRIALS
trial_result
· 2014-07-15
Clinical Trial Update: Dasatinib in Advanced Squamous Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial of dasatinib in advanced squamous cell carcinoma of the lung was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-15